Poliomyelitis
📧 Sign up to get email alerts when something new happens for Poliomyelitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine in 2, 4, 6 Months of Age [Phase 3]
Phase 3 trial update assessing safety and immunogenicity of an adjuvanted reduced-dose inactivated polio vaccine in infants aged 2, 4, and 6…
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: 3 Adjuvated Reduced Dose IPV-Al SSI and Non-adjuvated Full Dose IPV SSI Given as Primary Vaccinations to Infants [Phase 2]
A Phase 2 clinical trial comparing adjuvated reduced-dose IPV-aluminum SSI and non-adjuvated full-dose IPV-SSI as primary vaccinations in in…
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: Immunogenicity and Safety of Adjuvanted Reduced Dose Inactivated Polio Vaccine Given as a Booster at Age 15-18 Months [Phase 3]
Phase 3 trial update assessing immunogenicity and safety of an adjuvanted reduced-dose inactivated polio vaccine used as a booster at 15-18 …
-
CLINICAL_TRIALS trial_result · 2018-08-01Clinical Trial Update: Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants [Phase 3]
A Phase 3 trial assessing immunogenicity and safety of GSK Infanrix Hexa given at 2, 4, and 6 months in healthy infants; study completed wit…
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Fractional Inactivated Poliovirus Vaccine Booster and Rotavirus Study [Phase 4]
This clinical trial update reports the completion of a Phase 4 study evaluating a fractional inactivated poliovirus vaccine booster, along w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-03-22Clinical Trial Update: IPV Clinical Trial - The Gambia [Phase 4]
This is a Phase 4 clinical trial update for an inactivated poliovirus vaccine conducted in The Gambia, sponsored by the London School of Hyg…
-
CLINICAL_TRIALS trial_result · 2018-01-25Clinical Trial Update: Immunogenicity of Monovalent Type 2 Oral Poliovirus Vaccine [Phase 4]
Phase 4 trial update on the immunogenicity of monovalent type 2 oral poliovirus vaccine.
-
CLINICAL_TRIALS trial_result · 2017-11-08Clinical Trial Update: Immunogenicity and Safety Profile of Primary Dose of bOPV Bio Farma Given Simultaneously With Pentabio And IPV [Phase 4]
Phase 4 study evaluating the immunogenicity and safety of the primary dose of bOPV Bio Farma given simultaneously with Pentabio and IPV in h…
-
CLINICAL_TRIALS trial_result · 2017-10-19Clinical Trial Update: Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' IPV Vaccine (PoliorixTM) in Toddlers [Phase 3]
Phase 3 trial assessing safety and reactogenicity of GSK's IPV vaccine Poliorix in toddlers completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-09-11Clinical Trial Update: REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-old Children [Phase 3]
Phase 3 trial comparing REVAXIS® to DT Polio® as a second booster in 6-year-old children for diphtheria, tetanus, and poliomyelitis; study c…
-
CLINICAL_TRIALS trial_result · 2017-09-11Clinical Trial Update: Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE [Phase 4]
Phase 4 trial update on antibody persistence to REVAXIS or DT polio and immune response to TETRAVAC-ACELLULAIRE completed.
-
CLINICAL_TRIALS trial_result · 2017-09-11Clinical Trial Update: Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years Old [Phase 3]
Phase 3 trial assessing safety and immunogenicity of concomitant vs non-concomitant administration of REPEVAX and VAXIGRIP in adults aged 60…
-
CLINICAL_TRIALS trial_result · 2017-09-11Clinical Trial Update: Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older [Phase 3]
Phase 3 safety and immunogenicity update of REPEVAX followed by REVAXIS in adults 40+ years.
-
CLINICAL_TRIALS trial_result · 2017-08-31Clinical Trial Update: Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in INDIA (PROVIDE) [Phase 1]
A Phase 1 clinical trial investigating biological factors behind the underperformance of oral polio and rotavirus vaccines in India; study c…
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults [Phase 4]
Phase 4 trial reporting immunogenicity and safety of a booster dose of Boostrix Polio vaccine in adults previously boosted, with results pos…
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: Serological Survey on Monitoring the Positive Rate After Vaccination of Inactivated Polio Vaccine
This completed clinical trial evaluated serological positive rates following vaccination with the inactivated poliovirus vaccine.
-
CLINICAL_TRIALS trial_result · 2017-07-26Clinical Trial Update: Studies of the Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine [Phase 1, Phase 2]
Phase 1 and Phase 2 trials have completed evaluating the safety and immunogenicity of Sinovac's Sabin Inactivated Poliovirus Vaccine.
-
CLINICAL_TRIALS trial_result · 2017-07-05Clinical Trial Update: Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old Children [Phase 3]
Phase 3 trial update evaluating the immunogenicity and safety of GSK Boostrix Polio vaccine in 3- and 4-year-old children.
-
CLINICAL_TRIALS trial_result · 2017-07-05Clinical Trial Update: Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine [Phase 4]
This Phase 4 clinical trial update reports safety and immunogenicity results of a booster dose of GSK's Boostrix-Polio vaccine; results were…
-
CLINICAL_TRIALS trial_result · 2017-06-29Clinical Trial Update: Safety and Immunogenicity of IPOVAC in Young Children [Phase 2]
Phase 2 trial update evaluating the safety and immunogenicity of IPOVAC in young children with poliomyelitis; the study has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-26Clinical Trial Update: Immunogenicity and Reactogenicity of a Booster Dose of GSK Bio's DTPa-HBV-IPV/Hib Vaccine [Phase 2]
Phase 2 trial evaluating the immunogenicity and safety (reactogenicity) of a booster dose of GSK's DTPa-HBV-IPV/Hib vaccine, with results po…
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately [Phase 3]
Phase 3 trial compares the immunogenicity and reactogenicity of the hexavalent vaccine DTPa-HBV-IPV/Hib with the separate DTPa-HBV-IPV and H…
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly [Phase 2]
Phase 2 study assessing immunogenicity and safety of DTPa-HBV-IPV/Hib versus DTPa-IPV/Hib with concomitant hepatitis B administration, compl…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants [Phase 3]
Phase 3 trial comparing a DTaP-IPV-HepB-PRP-T vaccine with a DTaP-IPV-PRP-T vaccine plus Hep B in Hep B-primed infants has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Poliorix™ Vaccine [Phase 3]
Phase 3 immunogenicity and safety results for GlaxoSmithKline Poliorix vaccine completed with results posted in 2017.